What are the causes of thrombocytopenia (low platelet count)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Thrombocytopenia is primarily caused by decreased production of platelets, increased destruction of platelets, or sequestration of platelets, with immune thrombocytopenia (ITP) being a leading cause of increased destruction, as evidenced by the American Society of Hematology 2011 guideline 1. The causes of thrombocytopenia can be broadly categorized into three mechanisms:

  • Decreased production of platelets in the bone marrow, which can result from bone marrow disorders such as leukemia, aplastic anemia, myelodysplastic syndromes, or vitamin B12 and folate deficiencies, as well as certain medications that suppress platelet production, including chemotherapy drugs, alcohol, and some antibiotics.
  • Increased destruction of platelets in the peripheral circulation, which occurs in immune thrombocytopenia (ITP), where the immune system attacks platelets, and in conditions like disseminated intravascular coagulation (DIC), thrombotic thrombocytopenic purpura (TTP), and hemolytic uremic syndrome (HUS), with ITP being characterized by immunologic destruction of otherwise normal platelets, often in response to an unknown stimulus 1.
  • Sequestration of platelets in the spleen, which occurs in conditions causing splenomegaly, such as liver cirrhosis or portal hypertension, where the enlarged spleen traps platelets. Infections, particularly viral infections like HIV, hepatitis C, and COVID-19, can cause thrombocytopenia through various mechanisms, including increased destruction and decreased production, as noted in the international consensus report on the investigation and management of primary immune thrombocytopenia 1. Identifying the underlying cause of thrombocytopenia is crucial for appropriate management, as it can significantly impact morbidity, mortality, and quality of life, with the American Society of Hematology 2011 guideline providing evidence-based recommendations for the diagnosis and management of ITP 1.

From the FDA Drug Label

8 Hematologic Disorders Idiopathic thrombocytopenic purpura in adults Secondary thrombocytopenia in adults Acquired (autoimmune) hemolytic anemia Erythroblastopenia (RBC anemia) Congenital (erythroid) hypoplastic anemia

The causes of thrombocytopenia (low platelet count) mentioned in the label are:

  • Idiopathic thrombocytopenic purpura
  • Secondary thrombocytopenia 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.